Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases

Menglong Wang1,2,3, Wei Pan1,2,3, Yao Xu1,2,3

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.

Insights

Microglia, immune cells in the brain, are increasingly linked to cardiovascular diseases. Targeting microglia may offer new strategies for treating conditions like hypertension and heart attack.

Area of Science:

  • Neuroimmunology
  • Cardiovascular Science

Background:

  • Microglia are the primary immune cells within the central nervous system (CNS).
  • They play crucial roles in synaptic function and neuronal health.
  • Emerging evidence implicates microglia in the pathogenesis of cardiovascular diseases (CVDs).

Purpose of the Study:

  • To review the current understanding of microglia's role in cardiovascular diseases.
  • To explore the link between neuroinflammation, autonomic nervous system activity, and CVDs.
  • To highlight microglia as potential therapeutic targets for cardiovascular conditions.

Main Methods:

  • Literature review of recent studies on microglia and cardiovascular diseases.
  • Analysis of the interplay between neuroinflammation and autonomic dysfunction.
  • Synthesis of evidence regarding microglia's involvement in hypertension, myocardial infarction, and ischemia/reperfusion injury.

Main Results:

  • Microglial activation is observed in various cardiovascular diseases.
  • Modulating microglial activity can influence CVD incidence and progression.
  • Neuroinflammation-induced changes in autonomic activity may mediate microglial effects on the cardiovascular system.

Conclusions:

  • Microglia act as key neuroimmune modulators in the context of cardiovascular health.
  • Targeting microglia presents a promising therapeutic avenue for cardiovascular diseases.
  • Further research into the neuroimmune axis is crucial for developing novel CVD treatments.